Skip to content

The influence of different treatment modalities for uterine fibroids on pregnancy outcomes

The influence of different treatment modalities for uterine fibroids on pregnancy outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113860
Enrollment
Unknown
Registered
2025-12-04
Start date
2025-12-10
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Fibroid

Interventions

Control Group :Treatment with traditional laparoscopic myomectomy
Case Group :Treatment with high-intensity focused ultrasound (HIFU)

Sponsors

Shenzhen Maternity and Child Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1 Women aged 20-45 years 2 Single fibroid diameter of 4-15 cm or multiple fibroids with the largest diameter <=10 cm 3 Underwent HIFU or surgical (laparoscopic/open/hysteroscopic) treatment 4 Women who maintained pregnancy beyond 28 weeks with a viable fetus after treatment

Exclusion criteria

Exclusion criteria: 1 Non-reproductive age women 2 Type 0 submucosal uterine fibroids 3 Coexisting high-risk factors for pregnancy such as endometriosis/adenomyosis/hydrosalpinx 4 Malignant or borderline tumors

Design outcomes

Primary

MeasureTime frame
Incidence of adverse pregnancy outcomes;

Secondary

MeasureTime frame
Cesarean section rate; Pelvic adhesions;Birth weight;Interval from surgery to delivery;Gestational age at delivery;

Countries

China

Contacts

Public ContactYu Dai

Shenzhen Maternity and Child Healthcare Hospital

daiyu829@163.com+86 138 2871 8985

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026